Currently, aldosterone is believed to be involved in the development of cardiovascular injury as a potential cardiovascular risk hormone. However, its exact cellular mechanisms remain obscure. This study was undertaken to examine the effect of aldosterone on superoxide production in cultured rat aortic endothelial cells with possible involvement of the small GTP-binding (G) protein Rac1. The aldosterone levels showed a time-dependent (6 -24 h) and dose-dependent (10 ؊8 to 10 
A CCUMULATING LINES OF evidence suggest that the direct cardiovascular effects of aldosterone are responsible for inducing cardiovascular inflammation and fibrosis (aldosterone-induced vasculitis) (1) (2) (3) . In addition, a series of clinical studies have demonstrated a distinct benefit of mineralocorticoid receptor (MR) antagonism in cardiovascular diseases (4 -6) .
There are several sources of reactive oxygen species (ROS) in mammalian cells, including mitochondrial electron transport system, xanthine oxidase, cyclooxygenase, nitric oxide synthase, and reduced nicotinamide adenine dinucleotide phosphate [NAD(P)H] oxidase (7) . Among them, ROS derived from vascular NAD(P)H oxidase appears to be a major contributor for cardiovascular inflammation (7) (8) (9) . Aldosterone has recently been shown to increase superoxide production and induces cardiovascular injury in mineralocorticoid-induced hypertensive animals, whose effects were blocked by the administration of subpressor doses of MR antagonists as well as antioxidants and/or NAD(P)H oxidase inhibitors (3, 10 -13) . These experimental results suggest that oxidative stress induced by NAD(P)H oxidase plays an important role in the development of aldosterone-induced cardiovascular injury.
However, the molecular mechanism underlying vascular superoxide generation and NAD(P)H oxidase activation by aldosterone remains unknown.
A small G protein, Rac, has been shown to be involved in the activation of NAD(P)H oxidase in phagocyte as well as in nonphagocyte cells, including cardiovascular cells (7, 14) . Among several isoforms of Rac proteins, two isoforms (Rac1 and Rac2) play predominant roles in NAD(P)H oxidase activation (14) . In contrast to the limited expression of Rac2 only in hematopoietic cells, Rac1 expressed ubiquitously is considered to be mainly responsible for NAD(P)H oxidase activation in nonhematopoietic cells (14) .
It has been well recognized that endothelial damage is a primary event in the pathogenesis of cardiovascular diseases (15, 16) . Previously, we reported that aldosterone directly acts on endothelial cells to induce angiotensinconverting enzyme and osteopontin expression in vitro (17, 18) . In addition, we have recently reported marked increase in oxidant stress in the endothelium from aldosterone-induced hypertensive rats, the effect of which was eliminated by the selective MR antagonist eplerenone or the superoxide dismutase mimetic tempol (11) . These findings postulate that aldosterone possibly acts directly on endothelial cells to induce oxidative stress and vascular inflammation. However, the mechanism of the aldosterone effect on superoxide generation in endothelial cells remains unknown.
The present study aims to examine whether aldosterone directly stimulates NAD(P)H oxidase to generate superoxide in cultured rat aortic endothelial cells (RAECs) and, if so, to determine its molecular mechanism, particularly the potential involvement of the small G protein Rac1 in NAD(P)H oxidase activation. (19) and the sub360 adenovirus cosmid cS360loxP (19) were generous gifts from Elizabeth G. Nabel (National Heart, Lung, and Blood Institute, Bethesda, MD). Aldosterone and eplerenone were dissolved in dimethylsulfoxide (DMSO) at 10 Ϫ2 m in stock solution.
Materials and Methods Materials

Cell culture
RAECs were prepared from the thoracic aorta of 6-wk-old male Sprague Dawley rats fed with standard chow using the explants method as described previously (17, 18, 20) . Briefly, thoracic aorta was sterilely removed from a rat deeply anesthetized by an ip injection of sodium pentobarbital. The vessel was gently cleaned in Hanks' balanced salt solution and cut into flat segments of approximately 4 mm 2 . The flat aortic segments were placed endothelial-side down on Matrigel equilibrated with growth medium (medium 199 containing 10% fetal bovine serum and 15 g/ml endothelial cell growth supplement) in a 35-mm dish. The aortic explants were removed after 4 -8 d, depending on the degree of outgrowth of endothelial cells. Cells on Matrigel were passaged with 0.2% collagenase in Hanks' balanced salt solution and replated in growth medium onto a 60-mm type 1 collagen-coated dish. These RAECs were routinely subcultured by treatment with 0.05% trypsin and 0.02% EDTA. Characterization of isolated cells as endothelial cells was described previously (18) . Subcultured RAECs (fourth to seventh passages) were starved with medium 199 containing 0.5% calf serum (starvation medium) for 24 h and used for subsequent experiments. All of the experiments were conducted in starvation medium containing 0.1% DMSO; the medium containing 0.1% DMSO alone served as vehicle control.
Because the responses to aldosterone greatly varied depending on whether the cells were from different passage numbers and/or from the different rats (batch difference), cells from the same passage number derived from one animal were used for a series of each experiment to minimize the batch differences.
Measurement of intracellular superoxide anion levels
The intracellular superoxide anion level was measured using the cell-permeable dye DHE as previously described (21) . In brief, 1 ϫ 10 5 cells seeded and cultured on a 35-mm glass-bottom dish (Matsunami, Tokyo, Japan) for 24 h were subjected to serum starvation; 80 -90% confluent cells after 24 h starvation were treated with or without the test compound for the indicated duration. Cells were then incubated with 5 M DHE for 20 min at 37 C, washed in Krebs-Ringer phosphate buffer (15.9 mm NaH 2 PO 4 , 11 mm glucose, 1.2 mm MgSO 4 , 0.54 mm CaCl 2 , 4.8 mm KCl, and 120 mm NaCl) (pH 7.3), and imaged by inverted fluorescent microscopy under conditions of 514 nm excitation and 580 Ϯ 30 nm band pass filter (IX71; Olympus, Tokyo, Japan). Data analysis was performed as previously described (22, 23) .
Measurement of NAP(P)H oxidase activity
NAD(P)H oxidase activity was measured by the method described previously (23) with minor modification. Briefly, starved cells grown on 10-cm dishes were pretreated with or without eplerenone (3 ϫ 10 Ϫ7 m) for 1 h and stimulated with or without aldosterone (10 Ϫ8 m) for 12 h. After completion, cells were harvested, resuspended in lysis buffer composed of 5 ϫ 10 Ϫ2 m phosphate buffer (pH 7.0), containing 10 Ϫ3 m EGTA, 10 g/ml aprotinin, and 10 Ϫ3 m PMSF, and dounced on ice. An aliquot (50 g protein) of the lysate was brought into assay buffer composed of 5 ϫ 10 Ϫ2 m phosphate buffer (pH 7.0) containing 10 Ϫ3 m EGTA, 1.5 ϫ 10 Ϫ1 m sucrose, and 1 ϫ 10 Ϫ5 m dark-adapted lucigenin with or without 1 ϫ 10 Ϫ4 m DPI in a 96-well white assay plate (Corning, Rochester, NY). After preincubation at 37 C for 5 min, NADH (10 Ϫ4 m) was added, and luminescence was measured with a microplate luminometer (LB96V; Berthold Japan, Tokyo, Japan) over 1-min intervals for a total 15 min. NAD(P)H oxidase activity was measured as NAD(P)H oxidase-dependent superoxide anion (O 2 Ϫ ) production by integrated lucigenin chemiluminescence over 15 min without DPI subtracted from that with DPI.
Measurement of activated Rac1
The GTP-bound form of active Rac1 was measured using the Rac activation assay kit (Upstate Biotechnology) according to the affinity purification method by using the p21-activated kinase-1 (PAK-1) protein-binding domain peptide (24) . In brief, cells grown on 6-cm dishes were lysed with 250 l ice-cold lysis buffer [25 mm HEPES, 150 nm NaCl, 1% IGEPAL CA-630, 10 mm MgCl 2 , 10% glycerol, 1 mm EDTA, 10 g/ml leupeptin, 10 g/ml aprotinin, 1 mm NaF, and 1 mm NaVO 4 (pH 7.5)]. Each 25 l (10%) lysate was maintained for the subsequent immunoblot analysis for total Rac1 and actin, and the remaining lysates were incubated using 8 g PAK-1 protein-binding domain agarose for 1 h. After extensive washing with the lysis buffer, the agarose was boiled in Laemmli sample buffer. The affinity-purified samples or aliquots containing total cell lysates were resolved using 15% SDS-PAGE and analyzed by immunoblot analysis using the anti-Rac1 antibody or anti-actin antibody, as previously described (22) .
Gene transfer of the adenovirus vector
Replication-defective adenovirus encoding the dominant-negative form of Rac1 (RacN17) (25) or ␤-galactosidase (LacZ) was prepared by Cre/ loxP-mediated recombination between the sub3360 adenoviral cosmid (cS360loxP) and adenovirus shuttle plasmid (pAdCMV2295MCSloxP) inserted with each cDNA expression cassette (19) . Changing the amino acid residue from Ser to Asn at the position of 17 of Rac1 results in preferential affinity for GDP rather than GTP and behaves as dominant-negative mutant (26) . After confirmation of protein expression, each recombinant adenovirus was propagated in the HEK293 cells and purified by using cesium chloride gradient ultracentrifugation. Viral titers were determined by using a plaque assay methods.
With regard to the gene transfer study, RAECs were infected with 50 plaque-forming units virus per cell (multiplicity of infection, 50) in medium 199 containing 2% fetal calf serum for 2 h, followed by a 48-h incubation in medium 199 containing 10% fetal calf serum and starvation before the experiment.
Quantification of mRNA
Steady-state mRNA levels of rat ACE and osteopontin were quantified with a real-time quantitative RT-PCR using fluorescent SYBR Green technology (LightCycler; Roche Molecular Biochemicals, Mannheim, Germany) as described previously (17, 18) . Rat acid ribosomal phosphoprotein P0 (ARPP P0) mRNA levels were quantified by TaqMan fluorescence methods as described previously (17, 18) , except using QuantiTect Probe PCR Kit (QIAGEN, Valencia, CA) and LightCycler. Total RNA was extracted, first-strand cDNA synthesized, and amplification reaction performed as described (17, 18) . PCR primers, TaqMan probes, and size of each PCR product are as follows: ACE, forward 5Ј-CAGAGGCCAACTGGCATTAT-3Ј and reverse 5Ј-CTGGAAGT-TGCT CACGTCAA-3Ј, product size 137 bp; osteopontin, forward 5Ј-AGTGGTTTGCCTTTGCCTGTT-3Ј and reverse 5Ј-TCAGCCAAGTGG-CTACAGCAT-3Ј, product size 122 bp; ARPP P0 forward 5Ј-TAGAG-GGTGTCCGCAATGTG-3Ј, reverse 5Ј-GACAAAGCCAGGACCCTTT-TGT-3Ј, TaqMan probe 5Ј-ACCCGACTGTTGCCTCAGTGCCTCACT-CCA-3Ј, product size 107 bp.
Statistical analysis
Data are expressed as mean Ϯ sem. The differences between groups were examined for statistical significance using the t test or ANOVA with Dunn's post hoc test, if appropriate. P values Ͻ 0.05 were considered statistically significant.
Results
We first examined the effect of aldosterone on intracellular superoxide generation in RAECs by measuring DHE fluorescence. Aldosterone (10 Ϫ8 m) increased intracellular superoxide generation in a time-dependent manner (6 -24 h); a significant increase was observed as early as 6 h, and it peaked at 12 h (Fig. 1A) . Incubation with vehicle (0.1% DMSO) alone by 24 h did not affect intracellular ROS levels (Fig. 1A) or cell viability (data not shown). Treatment with aldosterone for 12 h increased intracellular superoxide levels in a dose-dependent manner (10 Ϫ8 to 10 Ϫ6 m); a significant increase was induced at a concentration as low as 10 Ϫ8 m and the peak at 10 Ϫ6 m (Fig. 1B) . The aldosterone-induced superoxide generation was blocked by pretreatment with the selective MR antagonist eplerenone (3 ϫ 10 Ϫ7 m) ( Fig. 2A ) and the NAD(P)H oxidase inhibitor apocynin (3 ϫ 10 Ϫ4 m) (Fig. 2B) . Therefore, aldosterone-induced superoxide generation results from MR-mediated NAD(P)H oxidase activation in endothelial cells.
Because Rac, a small G protein, has been shown to play a crucial role in NAD(P)H oxidase activation and superoxide generation (14), we examined the possible involvement of Rac in aldosterone-induced superoxide generation in RAECs using CD toxin A, a nonselective inhibitor of the small G proteins (Rho, Rac, and cdc42). CD toxin A (10 ng/ml) completely inhibited the aldosterone-induced superoxide generation (Fig. 2C) .
Because it has been shown that aldosterone activates NAD(P)H oxidase via Src in cultured rat vascular smooth muscle cells (VSMCs) (27) , we tested the effect of PP2, a selective Src inhibitor, on aldosterone-induced superoxide generation. PP2 (10 Ϫ5 m) completely inhibited the aldosterone-induced superoxide generation (Fig. 2D) .
To confirm that the aldosterone-indcued superoxide generation was derived from NAD(P)H oxidase, we measured NAD(P)H oxidase activity using a lucigenin chemiluminescence assay. Treatment with aldosterone (10 Ϫ8 m) showed a significant increase in NAD(P)H oxidase activity, whose effect was inhibited by eplerenone (Fig. 3) .
We then investigated whether aldosterone activates Rac1 in endothelial cells by measuring the levels of GTP-bound active Rac1. Aldosterone significantly (P Ͻ 0.05) increased the GTP-bound Rac1 levels in a time-dependent manner (6 -24 h) identical to that observed for superoxide generation, without affecting the total Rac1 protein levels (Fig. 4, A and  B) . Pretreatment with eplerenone abolished the aldosteroneinduced Rac1 activation (Fig. 4, C and D) , suggesting that aldosterone activates Rac1 via MR.
To further confirm the specific role of Rac1 in aldosteroneinduced superoxide generation in RAECs, the cells were subjected to gene transfer by using the recombinant dominant-negative Rac1 adenovirus (Ad-RacN17) and LacZ adenovirus (Ad-LacZ) as the control. As shown in Fig. 5 , gene transfer using Ad-RacN17 completely blocked the aldosterone-induced superoxide generation, whereas gene transfer with Ad-LacZ had no effect.
Because aldosterone increases ACE and osteopontin gene expression in RAECs (17, 18), we examined whether dominant-negative Rac1 affects ACE and osteopontin mRNA expression in response to aldosterone (10 Ϫ8 m). Gene transfer with Ad-RacN17 completely blocked the aldosterone-induced ACE mRNA expression, whereas that with Ad-LacZ was without effect (Fig. 6) . By contrast, gene transfer with either Ad-RacN17 or Ad-LacZ alone caused a marked decrease in osteopontin mRNA expression even under basal conditions, possibly due to a nonspecific effect by adenoviral particles (data not shown).
Discussion
The present study demonstrated for the first time that aldosterone induces superoxide generation via NAD(P)H oxidase and Rac1 activation through MR in RAECs. Aldosterone-induced superoxide generation was completely blocked by a nonselective small G protein inhibitor and adenoviral gene transfer of the dominant-negative Rac1, suggesting that aldosterone-induced Rac1 activation plays a crucial role in superoxide generation due to NAD(P)H oxidase in endothelial cells.
Recently, numerous experimental studies have revealed the potential direct role of aldosterone as a cardiovascular risk hormone in the development of cardiovascular disease via oxidative stress (1-3). There are several sources of ROS in mammalian cells, including mitochondrial electron transport system, xanthine oxidase, cyclooxygenase, nitric oxide synthase, and NAD(P)H oxidase. Because agonist-stimulated superoxide generation in cardiovascular cells is inhibited by dominant-negative Rac1 and antisense oligonucleotides for NAD(P)H oxidase components, NAD(P)H oxidasederived ROS appears to be largely responsible for the development of cardiovascular injury (7). In accordance with this, several recent studies have revealed that increased superoxide generation by NAD(P)H oxidase is involved in aldosterone-induced oxidative stress and inflammatory response in cardiovascular tissue, including cardiomyocytes and VSMCs (3, 10 -13) . We have recently reported that redoxsensitive proinflammatory gene expression and endothelial oxidative stress are hallmarks of vascular injury in the aldosterone-induced hypertensive rat model (11) . In the present study, we clearly demonstrated that the aldosterone-MR pathway stimulates superoxide generation via NAD(P)H oxidase in vascular endothelial cells. This result is almost in agreement with a recent report stating that aldosterone stimulates the formation of ROS in human umbilical vein endothelial cells (28) . Taken together with the previous data that aldosterone induces NAD(P)H oxidase activation in VSMCs (27) , the present data of aldosterone-induced NAD(P)H oxidase activation in endothelial cells lend support to the contention that oxidative stress derived from vascular NAD(P)H oxidase activation is largely responsible for the development of aldosterone-induced cardiovascular injury.
The cellular mechanism of NAD(P)H oxidase activation in phagocytes such as neutrophils and macrophages has been well characterized (8, 14, 29) ; activation of the small G protein Rac and phosphorylation of the p47phox trigger assembly comprising membrane (Nox and p22phox) and cytosolic components (p47phox, p67phox, p40phox, and Rac2) of NAD(P)H oxidase, leading to its complete activation. However, the mode of NAD(P)H oxidase activation by aldosterone in vascular cells has not been well characterized. Because Rac1 is a predominant Rac subtype in nonphagocyte cells (14), we examined the effect of aldosterone on the levels of GTP-bound (active) Rac1 in endothelial cells. In the present study, we demonstrated for the first time that aldosterone increased the GTP-bound form of Rac1 via MR in the same time as that required for superoxide generation in RAECs. Furthermore, we also demonstrated that Rac1 activation is indispensable for aldosterone-induced superoxide generation; the abovementioned result is based on the observations that inhibition of Rac by treatment with either CD toxin A or gene transfer of dominant-negative Rac1 abolished aldosterone-induced superoxide generation. In the present study, we also found that a src inhibitor, PP2, blocked the aldosterone-induced superoxide generation in RAECs, suggesting the possible involvement of Src in NAD(P)H oxidase activation. These findings complement the previous findings that aldosterone activates NAD(P)H oxidase via Src in VSMCs (27) . Because Rac1 activation is essential for the angiotensin II-mediated NA(D)PH oxidase activation with possible involvement of Src as an upstream signaling molecule in VSMCs (30), it appears that angiotensin II and al- dosterone share the Src-Rac pathway in common for NAD(P)H oxidase activation in vascular cells.
It is an important issue as to whether aldosterone-induced superoxide generation is via nongenomic or classical genomic action. Unfortunately, we could not obtain the conclusive evidence, because various doses of actinomycin D (1-10 M) and cycloheximide (5-20 g/ml) inhibited basal ROS generation by approximately 50% in RAECs, suggesting requirement of de novo gene expression for ROS generation in RAECs under the steady-state conditions (unpublished data). Nevertheless, genomic mechanism(s) for aldosterone on Rac1 activation seems likely because Rac1 activation and superoxide generation by aldosterone took longer times (at least 6 h).
We have reported that ACE gene expression by aldosterone was increased in RAECs in vitro (18) as well as in cardiovascular tissue in vivo (11) . In the present study, gene transfer of dominant-negative Rac1 abolished the aldosterone-induced ACE gene expression in RAECs, suggesting the possible involvement of Rac1 activation by aldosterone in ACE gene expression via a superoxide-dependent mechanism. In contrast, we have recently shown that treatment with tempol, a superoxide dismutase mimetic, did not affect the up-regulated ACE gene expression in aortic tissue from aldosterone-induced hypertensive rats (11) . Therefore, it is suggested that a diversity of molecular signaling mechanisms other than a redox-sensitive pathway are involved in ACE gene expression in cardiovascular tissue of aldosteroneinduced hypertension.
Recently, it has also been demonstrated that aldosterone decreased the expression and activity of glucose-6-phosphate dehydrogenase (G6PD) to reduce glutathione (GSH)-mediated redox regulation in bovine aortic endothelial cells after longterm (24 h) incubation, resulting in increased ROS levels and FIG. 5. Aldosterone-induced superoxide generation is blocked by adenovirus gene transfer of dominant-negative Rac1 (RacN17) in RAECs. RAECs were infected with Ad-LacZ or Ad-RacN17. RAECs treated without the virus were used as a mock-infection control. After 48 h, the cells were incubated with or without aldosterone (10 Ϫ8 M) for 12 h. DHE fluorescence was measured, and the data were calculated and plotted as described in Fig. 2 (A and B) and for 12 h (C and D). Rac activity was measured using PAK-1 affinity purification; total Rac1 and actin were detected by immunoblot analysis as described in Materials and Methods. A and C, Representative blots with GTP-Rac1 (top), totalRac1 (middle), and actin (bottom); B and D, the ratio of GTP-Rac1 to total Rac1 signals was quantified by densitometric scanning; each column shows fold increase over control and is the mean of three independent experiments. Closed and open columns indicate with and without aldosterone treatment, respectively. *, P Ͻ 0.05 vs. control; †, P Ͻ 0.05 vs. aldosterone without eplerenone.
decreased NO levels (31) . Consumption of GSH via increased NAD(P)H oxidase-derived superoxide and impaired GSH production due to decreased G6PD activity might contribute to the intracellular oxidative state and uncoupled endothelial NO synthase, which generates superoxide rather than NO (32) . Because aldosterone decreased G6PD expression and G6PD activities in endothelial cells and aortic tissue from C3H mice (31), we examined whether aldosterone affects G6PD expression in RAECs. However, treatment with aldosterone (10 Ϫ9 to 10 Ϫ7 m) for 24 h did not cause any changes in G6PD protein levels in RAECs (supplemental figure, published as supplemental data on The Endocrine Society's Journals Online web site at http:// endo.endojournals.org). Such a discrepancy might be accounted for by the different experimental conditions or species difference of endothelial cells examined. In contrast, the present study revealed that MR-mediated superoxide generation was activated by aldosterone via Rac1-dependent NAD(P)H oxidase in RAECs. Nevertheless, it is reasonable to speculate that aldosterone may use diverse signaling pathways in endothelial cells, including NAD(P)H oxidase activation and/or reduction in GSH-mediated redox regulation, thus constituting a vicious cycle for acceleration of endothelial dysfunction via oxidative stress.
In conclusion, our present study demonstrates that aldosterone induces superoxide generation via MR-mediated activation of NAD(P)H oxidase and Rac1 in vascular endothelial cells, thereby contributing to the development of aldosterone-induced vascular injury.
